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INTRODUCTION
Greatest concerns on the re-emergence of diphtheria epidemics came from a large-scale outbreak in the Newly 
Independent States (NIS) of the former Soviet Union, which involved 140 000 cases and 400 deaths during 1990-
1995. [1] This was further stigmatized by subsequent outbreaks of varying degrees in other parts of Western Europe 
and other countries through out the world. [2, 3] Recommendations and control strategies proposed by World Health 
Organization (WHO) have been successful for some countries in combating the disease. One of them was to asses 
diphtheria immunity levels among adults worldwide. [4, 5] However, data reported from the South East Asia region 
are very much lacking. As a result, our knowledge on the epidemiology of diphtheria is still inadequate. In a similar 
context, knowledge on the immunization policies of “high-risk” occupational groups in diphtheria outbreaks is also 
hampered by limited available data. In addition, critical issues on vaccine-preventable diseases in health-care workers 
(HCWs) and other high-risk groups have been extensively discussed. Recently, major improvements have been made 
by Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) 
in promoting tetanus, diphtheria and pertussis vaccine and other types of vaccines to all categories of health care 
workers.[6]
However, teachers, medical students or other important high-risk groups in health-related fields have been 
mistakenly underemphasized; and often marginalized because they are not considered hospital staff. [7, 8, 9] Furthermore, 
only a small number of systematic immunization programs exist for medical students and staff in medical institutions 
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ABSTRACT
Introduction: Little is known about the sero-prevalence of diphtheria anti-toxoid antibody levels 
among medical students in Malaysia. They too, just like other health care workers (HCWs) are at 
risk of contracting and transmitting diphtheria. Fortunately, this can be prevented by giving a specific 
vaccine: the diphtheria, tetanus and pertussis (DTP) vaccine. Nonetheless, data from local or regional 
surveys are needed before any decision is made by the respective authorities. General objective: We 
studied the epidemiology of diphtheria anti-toxoid antibody levels and vaccination history amongst 
medical students and staff in Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. 
Specific objectives: We determined the level of diphtheria anti-toxoid antibodies amongst pre-clinical 
students and staff. Methodology: A total of 152 sera were collected from subjects aged 19 to 63, and 
diphtheria anti-toxoid levels were measured by an enzyme-linked immunosorbent assay. Results: One 
hundred and fifty-two (94.4%) blood samples out of 161 participants were successfully withdrawn, 
which comprised 105 (69.1%) and 47 (30.9%) medical students and staff, respectively. A total of 77.6% 
and the other 22.4% of the subjects had full and basic protection, respectively. Higher levels were 
predominant amongst males and they were 1.3 times more protected than females in 20-29 year-old 
group (85.1% vs 66.2%; odd ratios 1.25 [95% CI 1.03-1.50]; P=0.03). No significant difference in the 
levels of immunity among subjects for ethnicity and academic position (P>0.05). Recommendations:
Level of full protection against diphtheria toxin should be clearly defined by broad population based 
studies using several comparable detection methods. Medical students and staff with basic protection 
should be closely monitored or should be given a booster dose for those who are at high risk of acquiring 
the disease. Thus, a standard degree of coverage should be clearly determined for health workers to 
prevent a potential outbreak. Conclusion: Students and staff possess immunity towards diptheria toxin 
however the level of full protective antibody is yet to be determined in future.
Keywords: Diphtheria, diphtheria anti-toxoid antibody, full protection, basic protection, 
medical students, staff
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worldwide. Special consideration is needed for these target groups as they are often exposed to infectious diseases 
directly or indirectly during clinical training. Now, it is recommended a one-time dose of Tdap for all HCWs including 
physicians and other primary-care providers such as nurses, aides, respiratory therapists, radiology technicians, 
students (e.g., medical, nursing, and other) that have direct contact with patient. This was supported by Healthcare 
Infection Control Practices Advisory Committee (HICPAC). [10]
However, experts propose that groups at risk should be clearly defined and evidence-based before any decision 
is made by the respective authorities. [2, 3] Thus, our aim in this study was to evaluate the immune status of medical 
students and staff members towards diphtheria in relation to the selected socio-demographical variables. We do hope 
that our findings would at least, in part, complement our national immunization coverage reports that have been 
submitted annually to WHO/UNICEF. Also, to provide additional input for policy-makers before embarking on new 
immunization programs for students who enter medical school.
MATERIALS AND METHODS
Study population
The cross-sectional study was conducted from January 2008 to July 2008 at the Faculty of Medicine and Health 
Sciences, University Putra Malaysia (UPM)—a public university in Peninsular Malaysia, approximately 30 kilometres 
from Kuala Lumpur. The participants consisted of pre-clinical (medical) students, and staff members. Informed 
consent was obtained and the following data was recorded in the standard Pro Forma: age, sex and ethnicity. Students 
and staff were ensured that the results would be kept confidential, and would be personally informed; advice about 
the risks and benefits of immunization were also provided. A standard questionnaire was also given to obtain the data 
on the history of DPT vaccination. The protocol and consent procedures were approved by the Ethical Committee of 
Universiti Putra Malaysia.
Serological method
Three millilitres of venous blood samples were obtained from the participants. The samples were allowed to clot 
naturally at room temperature, and the sera were collected and stored at –80°C for analyses. Measurement of specific 
IgG antibody against diphtheria toxoid levels in International Unit (IU/ml) was performed by using ELISA (enzyme-
linked immunosorbent assay, VaccZymeTM Diphtheria Toxoid IgG, The Binding Site Ltd., United Kingdom). The 
relative sensitivity and specificity of this kit as compared with the gold standard Vero Cell Assay (VCA) are 93.06% 
and 91.82%, respectively. 
All procedures and interpretations were done according to the manufacturer’s guidelines. Briefly, 100 µl of each 
calibrator, control and 1: 100 diluted sample were added to the appropriate wells, all of which were coated with 
diphtheria toxoid antigen derived from Corynebacterium diphtheriae. Following incubation for 30 minutes; all 
unbound proteins in the wells were discarded by washing three times. One hundred (100) µl of purified peroxidase-
labeled rabbit anti-human IgG used as conjugate were added and again re-incubated for another 30 minutes. The 
wells were washed three times to remove excess unbound conjugate. Finally, 100 µl of tetramethylbenzidine (TMB) 
were added as substrate and subsequently incubated in a dark room for 30 minutes to give blue reaction product. The 
intensity of the reaction was determined by using DYNATEX Microplate Reader (USA) at optical density (OD) of 
450 nm. The measurement was done within 30 minutes of stopping the reaction using 100 µl of phosphoric acid. All 
procedures were carried out at room temperature. 
The results were interpreted as follows based on the manufacturer’s guideline:
 Diphtheria immunity status:
 < 0.01 IU/ml:  No protection
 0.01 to 0.1 IU/ml: Basic protection
 > 0.1 IU/ml:  Full protection 
Statistical analysis
Data analysis was carried out by using SPSS version 16.0 software (SPSS Inc., Chicago, IL, USA). Pearson chi square 
and Fisher’s exact tests were used to analyze the association of the various socio-demographical variables with the 
prevalence of diphtheria antitoxins. P values < 0.05 were considered to be statistically significant.
RESULTS
One hundred and fifty-two (94.4%) blood samples out of 161 participants were successfully withdrawn, of whom 
100 (65.8%) and 52 (34.2%) were females and males, respectively. Their ages ranged from 19 to 63 years (median 
21.0 years, standard deviation [SD] 6.2 years). The remaining 9 participants were excluded, as their blood could not 
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be taken for various reasons. Of 152, 105 (69.1%) comprised medical students and 47 (30.9%) staff. The ethnicity 
distribution was as follows: 99 (65.1%) Malays, 44 (28.9%) Chinese, 6 (3.9%) Indians and the remainder, 3 (2.0%) 
were of other ethnic groups. Overall, 147 (97.2%) received diphtheria, tetanus and pertussis (DTP) vaccine as primary 
immunization and a booster dose at school entry. All of the participants (100%) were serologically immune. One 
hundred and eighteen (77.6%) and 34 (22.4%) of them had full and basic protection, respectively. The prevalence of 
diphtheria immunity status according to socio-demographic characteristics is shown in Table 1. The median diphtheria 
anti-toxoid antibody concentration reached 0.21 IU/ml (quartiles Q25–Q75; 0.1 to 0.37; Table 2).










Age-group ( in years)
< 20 0 (0.0) 3 (100.0) 0.084
20–29 34 (25.8) 98 (74.2)
30–39 0 (0.0) 14 (100.0)
>39 0 (0.0) 3 (100.0)
Gender
Male 7 (13.5) 45 (86.5) 0.057
Female 27 (27.0) 73 (73.0)
Ethnicity
Malay 22 (22.2) 77 (77.8) 0.549
Chinese 11 (25.0) 33 (75.0)
Indian 0 (0.0) 6 (100.0)
Others 1 (33.3) 2 (66.7)
Academic position
Medical lecturer 0 (0.0) 10 (100.0) 0.266
Tutor 0 (0.0) 4 (100.0)
Science officer 1 (33.3) 2  (66.7)
Laboratory personnel 7 (31.8) 15 (68.2)
Administrative staff 3 (37.5) 5 (62.5)
Medical student 23 (21.9) 82 (78.1)
Vaccination among subjectsa
Completed 34 (23.1) 113 (76.9) 0.446
Not sure 0 (0.0) 5(100.0)
a History of diphtheria vaccination was considered completed if three doses of toxoid given at 3, 4, and 5 
months of age as primary immunization in combined vaccine against DPT, followed by a fourth dose at 
18 months, and a booster dose at school entry, between 6 and 7 years of age were documented.
In general, 86.5% of the males had full protective diphtheria anti-toxoid levels whereas; only 73.0% of the females 
were fully protected. The difference was not statistically significant (P=0.06; Table 1). The median diphtheria anti-
toxoid antibody concentration in males was 0.18 IU/ml (0.12–0.32) compared with 0.22 IU/ml (0.09–0.39) in females 
(Table 2). However, when gender in the 20–29 year-old category was analyzed on those with  full protective diphtheria 
anti-toxoid levels (Figure 1), significant difference was observed (P =0.03, data is not shown). Males (85.1%) had 
higher percentages of full protective diphtheria anti-toxoid levels than females (66.2%) among this group, and  males 
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were the most predominant and 1.3 times more protected than females in 20-29 year-old group (odd ratios 1.25 [95% 
CI 1.03-1.50]).
Characteristics












Table 2. Diphtheria anti-toxoid antibody concentration (IU/ml) according 
to academic position, gender and ethnicity
Figure 1. Distribution of full protective diphtheria anti-toxoid 
levels in 98 participants of 20 to 29-year-old age group 
according to gender
With reference to ethnicity, levels of full protection were found in 77 (77.8%), 33 (75%), 6 (100%) and 2 (66.7%) 
of Malays, Chinese, Indians and others, respectively. However, neither ethnicity nor academic position had statistically 
significant difference (Table 1; P >0.05). In general, the median diphtheria anti-toxoid antibody concentration in 
Malays (0.22 IU/ml; quartiles Q25–Q75; 0.10–0.39) was slightly higher than non-Malays (0.17 IU/ml; quartiles Q25–
Q75; 0.10–0.32; Table 2). Overall, medical students and staff seemed to have equal percentages of full protective 
diphtheria anti-toxoid levels, i.e., 82 (78.1%) and 36 (76.6%) of students and staff, respectively (Figure 2). However, 
median diphtheria anti-toxoid antibody concentration in staff members (0.31 IU/ml; quartiles Q25–Q75; 0.10–0.44) 
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was higher than medical students (0.18 IU/ml; quartiles Q25–Q75; 0.10–0.38; Table 2). Nevertheless, small number 
of subjects (staff) may contribute to this finding.
DISCUSSION
In our present study, we documented that 78.1% of medical students had full protective diphtheria anti-toxoid levels (> 
0.1 IU/ml). The remaining 21.9% had basic protective levels (0.01—0.1 IU/ml). Importantly, all of them (100%) had 
immunity to diphtheria. This is not surprising, as most of them were born after the year of commencement of Extended 
Program on Immunization (EPI) [11], which was started in 1989. And also, this probably reflects highly sustainable 
immunization coverage of diphtheria, tetanus and pertussis (DTP) of more than 90% in our country since 1990. [12] Our 
findings are also comparable to previous studies, which reported 68.3 % and 78.4% of medical students in London [13]
and Poland [14] respectively, were fully protected. As high protective levels are vital in this group, a booster dose might 
be required in those who had basic protection. Several studies have reported that high immunity levels were required 
for full protection. [15] In a different scenario, it is well documented that at least 70% of children must be immunized in 
order to prevent major outbreaks of diphtheria in the community. [16] However, so far, no general consensus has been 
proposed for HCWs, including medical students and staff as to what percentage to be achieved in order to prevent 
nosocomial or institutional outbreaks. 
As for staff members, 76.6% were fully protected and 23.4% had basic protection. Again, all of them (100%) 
were immune to diphtheria toxin. Surprisingly, higher concentration of anti-toxoid antibody was found in our staff 
(0.31 IU/ml) than medical students (0.18 IU/ml; Table 2) in general. As for comparison, our prevalence rate of full 
protection is very much higher than reported in other studies. Lower prevalence rates of 26%, 51% and 57% were 
reported in Germany [17], United Kingdom [18] and Australia [19], respectively. Recently, only 36.3% of infection control 
staff in Japan was reported to have full protective levels against diphtheria antitoxin. [20] However, different values of 
these percentages were attributed to the different study designs and methodologies, vaccination programs and types 
of serological test used. Our result may also probably signify the effectiveness of vaccine surveillance networks and 
good public health infrastructures. These are very important and possibly explain lower levels of full protection in 
underprivileged and minority populations in Thailand despite persistently high immunization coverage, which was 
more than 90% reported annually in that country. [21]
In addition, for adults in highly developed countries, a booster dose is given to them before they are recruited into 
the army, which might probably explain high levels of protective immunity. [22,23]  As for our case, it may be related to 
our national immunization policy. In Malaysia, the national policy of diphtheria immunization includes three doses 
of toxoid given at 3, 4, and 5 months of age as primary immunization in combined vaccine against DPT, followed 
by a fourth dose at 18 months, and a booster dose at school entry, between 6 and 7 years of age. [24] Because of the 
boostering effects, this may probably contribute to higher prevalence of full protection in our study. It is well known 
Figure 2. Distribution of diphtheria immunity status according to 
academic position (basic protection: 0.09–0.1 IU/ml; full 
protection: > 0.1 IU/ml)
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that booster effects can be maintained for up to 30 years. [25] One study reported 90% of respondents produced more 
than or equal to 1 IU/ml of antitoxins following a booster after one-month period. [26] Also, the acquisition rate of fully 
protective level was higher among young adults as reported in Japan. [20] This was also supported by a study in Israel 
that reported adults acquired higher protective antitoxin levels following a booster dose injection given to them at 18 
years of age. [27]
However, experts postulated that other factors rather than vaccination alone could possibly play a role. Changes 
in socioeconomic and lifestyle would give different epidemiological patterns of the disease. [20] Based on these 
observations, higher percentages of full protection found in both medical students and staff may also be related to 
these factors. Malaysia is now recognized as a rapidly industrialized country with high standard of living. Also, our 
socio-economic stability might have provided equal opportunities of vaccination among our participants. However, 
local data on age-related difference in diphtheria cases was not available for further analyzes. The limitation of this 
study is that we did not conduct a population based randomized study, and therefore a recruitment bias is possible. 
However, as immunity levels in HCWs are of the main priority, this can be accepted. 
In this present study, males (86.5%) had significantly higher percentage of full protection than females (73%) in 
general (Table 1). However, the difference was not statistically significant (P=0.06). Interestingly, in the 20-29-year-old 
group, males were 1.2 times more likely to have full protective antibodies than females (odd ratios 1.25 [95% CI 1.03-
1.50]). Forty (85.1%) out of 47 males in this group, were fully protected as compared to females (68.2%); (data not 
shown). The difference was statistically significant (P=0.03; Figure 2). With regard to gender-related difference, many 
conflicting results were documented; and multiple contributing factors were proposed. [27] Some of them remained 
poorly understood. [28, 29] In several studies, routine administration of Tetanus-Diphtheria toxoids vaccine (Td) for 
injury cases—men were more prone, was responsible for higher protection rates in males [3, 30, 31], as well as, a booster 
dose given prior to army’s recruitment (mostly males). [2] Different immunization responses in females following 
vaccination were also responsible for the finding. Lower antibody titres and shorter period in maintaining immunity 
levels in females were reported in several studies. [22, 29] In our case, the concentrations of anti-toxoid in males (0.18 
IU/ml) and females (0.22 IU/ml) were almost equal (Table 2). In contradiction, few studies reported that males had 
lower protection rates than females. [32, 33] Nevertheless, neither Td vaccination nor booster dose is recommended for 
such occasions in Malaysia. In our study, ethnicity of different origin was not statistically associated with diphtheria 
immunity status. This was in accordance with previous studies conducted in Israel. [27]  
CONCLUSION
In summary, our study revealed that medical students and staff members possess immunity to diphtheria toxin. Hence, 
the risk for contracting and transmitting the disease is relatively minimal. For this reason, it might not be necessary 
to institute a specific vaccination program for diphtheria in our medical school and institution. However, our findings 
will not be similar to medical schools in other developing countries and the full protective immunity is yet to be further 
determined. Each country should analyze data gathered from its local and national surveys before formulating specific 
recommendations on diphtheria vaccination.
ACKNOWLEDGEMENTS
The authors would like to thank the Dean of the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 
for permission to conduct the study. Special thanks are extended to Dr Androulla Efstratiou and Professor Farida Jamal 
for their support and encouragement. We are also indebted to our medical students: Chua Yi Jiang, Seng Kit Leng, 
Zubaidah Mohamad for performing the serum antibody analyses and technical assistance and also to all anonymous 
reviewers for their valuable comments. This work was funded by the Research University Grant Scheme (RUGS) 
Project No. 04-02-07-0340RU and was supported by the Department of Medical Microbiology and Parasitology, 
Faculty of Medicine and Health Sciences, Universiti Putra Malaysia.
REFERENCES
[1] Dittmann S, Wharton M, Vitex C, Ciotti M, Galazka A, Guichard S et al. Successful control of epidemic 
diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000; 
181: S10-22.
[2] Galazka A, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol 1995; 11: 95-105.
[3] Galazka AM, Robertson SE. Immunization against diphtheria with special emphasis on immunization of adults. 
Vaccine 1996; 14: 845-57.
[4] World Health Organization: The control of diphtheria in Europe; 1990 April, Geneva, Switzland. Report EUR/-
Malaysian Journal of Medicine and Health Sciences Vol. 7 (1) January 2011
Diphtheria Anti-toxoid Antibody Levels Among Pre-clinical Students and Staff in an Institute of Higher Learning in Malaysia 33
ICP/EPI 024 5582 r.
[5] Dittmann S, Roure C. Diphtheria Plan of Action for the Prevention and Control of Diphtheria in the European 
Region (1994–1995). The Expanded Programme on Immunization in the European Region of WHO, ICP: EPI 
038(A). Copenhagen: WHO 1994.
[6] Centers for Disease Control and Prevention. Immunization of health-care workers: recommendations of Advisory 
Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee 
(HICPAC). Morb Mortal Wkly Rep 1997; 46(RR-18): 1-42.
[7] Lane NE, Paul RI, Bratcher DF, Stover BH. A survey of policies at children’s hospitals regarding immunity of 
healthcare workers: are physicians protected? Infect Control Hosp Epidemiol 1997; 18: 400-40.
[8] Murray DL, Lynch MA. Determination of immune status to measles, rubella, and varicella-zoster viruses among 
medical students. Assessment of historical information. Am J Public Health 1988; 78: 836-38. 
[9] McRae AT 3rd, Stephens JL. Hepatitis B virus vaccination of medical students: a call for rigorous standards. 
JAMA 1995; 274: 1081.
[10] Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adults: use of 
tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Morb Mortal Wkly Rep 2006; 55(RR-
17): 1-33. 
[11] World Health Organization 1984. Expanded program on immunization. Feasibility of elimination of vaccine-
preventable disease. Wkly Epidemiol Rec 1984; 59: 143-5.
[12] WHO and UNICEF, WHO UNICEF review of national immunization coverage, 1980–2007 http://www.who.
int/immunization_monitoring/en/globalsummary/wucoveragecountrylist.cfm (accessed December 16, 2008).
[13] Sheffield FW, Ironside AG, Abbott JD. Immunization of adults against diphtheria. BM J 1978; 2: 249-50.
[14] Expanded Programme on Immunization. Immunization of adults against diphtheria. Wkly Epidemiol Rec 1995; 
8; 56-9.
[15] Baer G, Bonhoeffer J, Schaad UB, Heininger U. Seroprevalence and immunization history of selected vaccine 
preventable diseases in medical students. Vaccine 2004; 23(16): 2016-20.
[16] Mortimer EA. Diphtheria toxoid. In: Plotkin SA and Mortimer EA (ed): Vaccines. W. B. Saunders, Philadelphia, 
1994, p. 41-56. 
[17] John C, Selzer G, Preiser W, Zielen S. Diphtheria immunity in health staff. Lancet 1996; 347: 969.
[18] Maple PA, George RC, Miller E, Morgan-Capner P, Hayward P. Diphtheria immunity in adults. Lancet 1996; 
348: 964.
[19] Hanlon M, Isaacs D, Kakakios A. Diphtheria immunity in health staff. Lancet 1996; 347: 1839-40.
[20] Nakajima H, Kariya H, Ohata R, Ogura H. Investigation of immunity level against diphtheria and reinforcement 
of immunity by booster vaccination for infection control staff in Okayama Prefecture. Jpn J Infect Dis 2008; 61: 
104-6.
[21] Tharmaphornpilas P, Yoocharoan P, Prempree P, Youngpairoj S, Sriprasert P et al. Diphtheria in Thailand in the 
1990s. J Infect Dis 2001; 184: 1035-40.
[22] Simonsen O. Vaccination against tetanus and diphtheria: evaluation of immunity in the Danish population, 
guidelines for revaccination, and the methods for control of vaccination programs. Dan Med Bull 1989; 36: 24-
47.
Malaysian Journal of Medicine and Health Sciences Vol. 7 (1) January 2011
RA Hamat, O Malina, YJ Chua, KL Seng, M Zubaidah, K Norhanim, SS Chong, PL Weng, & J Farida34
[23] World Health Organization. Diphtheria immunity in the adult French population. Wkly Epidemiol Rec 1995; 70: 
252-5.
[24] Ministry of Health Malaysia. Clinical Practice Guidelines on Childhood Immunization. 2002.http://www.moh.
gov.my (accessed May 20, 2009).
[25] World Health Organization 2006. Diphtheria vaccine. WHO position paper. Wkly Epidemiol Rec 2006; 81: 21-
32.
[26] World Health Organization 1995. Expanded program on immunization. Immunization of adults against diphtheria. 
Wkly Epidemiol Rec 1995; 70: 53-60.
[27] Valinsky L, Simhoni S, Bassal R et al. Prevalence and correlates of diphtheria toxoid antibodies in children and 
adults in Israel. ESCMID 2006; 12(10): 968-73.
[28] Galazka AM. Changing epidemiology of diphtheria in the vaccine era. J Infect Dis 2000; 118(Suppl 1): S2-9.
[29] Galazka AM, Robertson SE. Diphtheria: changing patterns in the developing world and the industrialized world. 
Euro J Epidemiol 1995; 11: 107-17.
[30] Ruben FL, Nagel J, Fireman P. Antitoxin responses in the elderly to tetanus-diphtheria (Td) immunization. Am 
J Epidemiol 1978; 108: 145-9.
[31] Kjeldsen K, Simonsen O, Heron I. Immunity against diphtheria 25-30 years after primary vaccination in 
childhood. Lancet 1985; i: 900-2.
[32] Jenum PA, Skogen V, Danilova E, Eskild A, Sjursen H. Immunity to diphtheria in northern Norway and north-
western Russia. Eur J Clin Microbiol Infect Dis 1995; 14: 794-8.
[33] de Melker HE, Berbers GA, Nagelkerke NJ, Conyn-van Spaendonck MA. Diphtheria antitoxin levels in the 
Netherlands: a population-based study. Emerg Infect Dis 1999; 5: 694-700.
